These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 26115070)

  • 1. Reproducibility and biological variability of HDL's vascular functional assays.
    O'Neill F; McLoughlin E; Riwanto M; Manz J; Adler A; Sutill E; Khan T; Haywood R; Kay CW; D'Aiuto F; Charakida M; Landmesser U; Deanfield J
    Atherosclerosis; 2015 Aug; 241(2):588-94. PubMed ID: 26115070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional changes in HDL with low grade and chronic inflammation.
    O'Neill F; Riwanto M; Charakida M; Colin S; Manz J; McLoughlin E; Khan T; Klein N; Kay CW; Patel K; Chinetti G; Staels B; D'Aiuto F; Landmesser U; Deanfield J
    Int J Cardiol; 2015 Jun; 188():111-6. PubMed ID: 25919891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females.
    Ferretti G; Bacchetti T; Moroni C; Savino S; Liuzzi A; Balzola F; Bicchiega V
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1728-33. PubMed ID: 15613429
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies to high-density lipoprotein and beta2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome.
    Delgado Alves J; Ames PR; Donohue S; Stanyer L; Nourooz-Zadeh J; Ravirajan C; Isenberg DA
    Arthritis Rheum; 2002 Oct; 46(10):2686-94. PubMed ID: 12384928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endothelial-vasoprotective effects of high-density lipoprotein are impaired in patients with type 2 diabetes mellitus but are improved after extended-release niacin therapy.
    Sorrentino SA; Besler C; Rohrer L; Meyer M; Heinrich K; Bahlmann FH; Mueller M; Horváth T; Doerries C; Heinemann M; Flemmer S; Markowski A; Manes C; Bahr MJ; Haller H; von Eckardstein A; Drexler H; Landmesser U
    Circulation; 2010 Jan; 121(1):110-22. PubMed ID: 20026785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients.
    Ferretti G; Bacchetti T; Busni D; Rabini RA; Curatola G
    J Clin Endocrinol Metab; 2004 Jun; 89(6):2957-62. PubMed ID: 15181084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzymatic assessment of paraoxonase 1 activity on HDL subclasses: a practical zymogram method to assess HDL function.
    Gugliucci A; Caccavello R; Kotani K; Sakane N; Kimura S
    Clin Chim Acta; 2013 Jan; 415():162-8. PubMed ID: 23122967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of paraoxonase 1 is associated with HDL remodeling ex vivo.
    Gugliucci A
    Clin Chim Acta; 2014 Feb; 429():38-45. PubMed ID: 24280342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Administration of high dose eicosapentaenoic acid enhances anti-inflammatory properties of high-density lipoprotein in Japanese patients with dyslipidemia.
    Tanaka N; Ishida T; Nagao M; Mori T; Monguchi T; Sasaki M; Mori K; Kondo K; Nakajima H; Honjo T; Irino Y; Toh R; Shinohara M; Hirata K
    Atherosclerosis; 2014 Dec; 237(2):577-83. PubMed ID: 25463091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased LCAT activity and hyperglycaemia decrease the antioxidative functionality of HDL.
    Kappelle PJ; de Boer JF; Perton FG; Annema W; de Vries R; Dullaart RP; Tietge UJ
    Eur J Clin Invest; 2012 May; 42(5):487-95. PubMed ID: 21955281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDL levels and oxidizability during myocardial infarction are associated with reduced endothelial-mediated vasodilation and nitric oxide bioavailability.
    Carvalho LS; Panzoldo N; Santos SN; Modolo R; Almeida B; Quinaglia E Silva JC; Nadruz W; de Faria EC; Sposito AC;
    Atherosclerosis; 2014 Dec; 237(2):840-6. PubMed ID: 25463131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High density lipoprotein from patients with valvular heart disease uncouples endothelial nitric oxide synthase.
    Chang FJ; Yuan HY; Hu XX; Ou ZJ; Fu L; Lin ZB; Wang ZP; Wang SM; Zhou L; Xu YQ; Wang CP; Xu Z; Zhang X; Zhang CX; Ou JS
    J Mol Cell Cardiol; 2014 Sep; 74():209-19. PubMed ID: 24887036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase.
    Aviram M; Rosenblat M; Bisgaier CL; Newton RS; Primo-Parmo SL; La Du BN
    J Clin Invest; 1998 Apr; 101(8):1581-90. PubMed ID: 9541487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of serum amyloid A and sphingosine-1-phosphate on high-density lipoprotein functionality.
    Prüfer N; Kleuser B; van der Giet M
    Biol Chem; 2015 Jun; 396(6-7):573-83. PubMed ID: 25252751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The acute-phase protein serum amyloid A induces endothelial dysfunction that is inhibited by high-density lipoprotein.
    Witting PK; Song C; Hsu K; Hua S; Parry SN; Aran R; Geczy C; Freedman SB
    Free Radic Biol Med; 2011 Oct; 51(7):1390-8. PubMed ID: 21784147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus.
    Lakshman MR; Gottipati CS; Narasimhan SJ; Munoz J; Marmillot P; Nylen ES
    Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective action of Ilex paraguariensis extract against free radical inactivation of paraoxonase-1 in high-density lipoprotein.
    Menini T; Heck C; Schulze J; de Mejia E; Gugliucci A
    Planta Med; 2007 Sep; 73(11):1141-7. PubMed ID: 17823869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gender-specific correlation between plasma myeloperoxidase levels and serum high-density lipoprotein-associated paraoxonase-1 levels in patients with stable and unstable coronary artery disease.
    Yunoki K; Naruko T; Inaba M; Inoue T; Nakagawa M; Sugioka K; Ohsawa M; Iwasa Y; Komatsu R; Itoh A; Haze K; Yoshiyama M; Becker AE; Ueda M
    Atherosclerosis; 2013 Dec; 231(2):308-14. PubMed ID: 24267244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-density lipoprotein from patients with coronary heart disease loses anti-thrombotic effects on endothelial cells: impact on arterial thrombus formation.
    Holy EW; Besler C; Reiner MF; Camici GG; Manz J; Beer JH; Lüscher TF; Landmesser U; Tanner FC
    Thromb Haemost; 2014 Nov; 112(5):1024-35. PubMed ID: 25056722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased carbamylation level of HDL in end-stage renal disease: carbamylated-HDL attenuated endothelial cell function.
    Sun JT; Yang K; Lu L; Zhu ZB; Zhu JZ; Ni JW; Han H; Chen N; Zhang RY
    Am J Physiol Renal Physiol; 2016 Mar; 310(6):F511-7. PubMed ID: 26764205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.